Fayez Sarofim & CO Amgen Inc Transaction History

Fayez Sarofim & CO

$38.7 Billion
Q3 2024

A detailed history of Fayez Sarofim & CO transactions in Amgen Inc stock. As of the latest transaction made, Fayez Sarofim & CO holds 24,602 shares of AMGN stock, worth $7.25 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

24,602

Previous 24,162 1.82%

Holding current value

$7.25 Million

Previous $7.55 Million 5.01%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $136,127 - $148,447	440 Added 1.82%	24,602 $7.93 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $167,371 - $203,400	-637 Reduced 2.57%	24,162 $7.55 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $45,976 - $55,499	-171 Reduced 0.68%	24,799 $7.05 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $205,582 - $231,921	-804 Reduced 3.12%	24,970 $7.19 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $120,257 - $149,303	-550 Reduced 2.09%	25,774 $6.93 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $5,142 - $6,080	24 Added 0.09%	26,324 $5.84 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $375,037 - $457,107	1,661 Added 6.74%	26,300 $6.36 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $17,177 - $21,825	-75 Reduced 0.3%	24,639 $6.47 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $28,281 - $31,896	126 Added 0.51%	24,714 $5.57 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $285,618 - $317,844	-1,238 Reduced 4.79%	24,588 $5.98 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $428,453 - $473,981	1,954 Added 8.19%	25,826 $6.25 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $1.83 Million - $2.09 Million	9,204 Added 62.75%	23,872 $5.37 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $876,038 - $1.03 Million	-4,127 Reduced 21.96%	14,668 $3.12 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $311,595 - $345,692	-1,334 Reduced 6.63%	18,795 $4.58 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $2.6 Million - $3.03 Million	-11,720 Reduced 36.8%	20,129 $5.01 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $262,468 - $312,553	1,213 Added 3.96%	31,849 $7.32 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $22,761 - $25,312	-97 Reduced 0.32%	30,636 $7.79 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $1.05 Million - $1.29 Million	5,299 Added 20.83%	30,733 $7.25 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $63,784 - $84,595	350 Added 1.4%	25,434 $5.16 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $193,561 - $248,793	1,023 Added 4.25%	25,084 $6.05 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $18,803 - $22,530	-108 Reduced 0.45%	24,061 $4.66 Million
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $4,500 - $5,276	-27 Reduced 0.11%	24,169 $4.45 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $762,005 - $858,946	-4,213 Reduced 14.83%	24,196 $4.6 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $82,599 - $96,419	463 Added 1.66%	28,409 $5.53 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $402,837 - $452,473	-2,426 Reduced 7.99%	27,946 $5.16 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $30,497 - $35,640	-180 Reduced 0.59%	30,372 $5.18 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $761,749 - $851,106	-4,513 Reduced 12.87%	30,552 $5.31 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $5.87 Million - $6.7 Million	35,065	35,065 $6.54 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Account